Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Biasco

Showing results (31-40 of 169) with videos related to

Pageof 17
Sort By:
Oncotarget|July 6, 2015
Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapiesGiovanni Brandi, Andrea Farioli, Annalisa Astolfi, et al.
Journal of Translational Medicine|June 5, 2017
Erratum to: The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)Margherita Nannini, Milena Urbini, Annalisa Astolf, et al.
Journal of Translational Medicine|May 25, 2017
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)Margherita Nannini, Milena Urbini, Annalisa Astolfi, et al.
Histology and Histopathology|October 17, 2013
Insulin-like Growth Factor (IGF) system and gastrointestinal stromal tumours (GIST): present and futureMargherita Nannini, Guido Biasco, Annalisa Astolfi, et al.
Hepatology (Baltimore, Md.)|December 24, 2016
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible preventionGiovanni Brandi, Stefania De Lorenzo, Andrea Palloni, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 18, 2012
Hedgehog signaling: from the cuirass to the heart of pancreatic cancerMariacristina Di Marco, Marina Macchini, Silvia Vecchiarelli, et al.
Journal of Translational Medicine|August 16, 2014
Liquid biopsy in gastrointestinal stromal tumors: a novel approachMargherita Nannini, Annalisa Astolfi, Milena Urbini, et al.
Cutaneous and Ocular Toxicology|March 29, 2013
Cutaneous leukocytoclastic vasculitis due to erlotinib: just an adverse event or also a putative marker of drug efficacy?Giovanni Brandi, Michela Venturi, Emi Dika, et al.
Cancer Treatment Reviews|November 17, 2009
Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapyMaria Abbondanza Pantaleo, Margherita Nannini, Monica Di Battista, et al.
European Urology|July 29, 2008
Durable complete response to frontline docetaxel in an advanced prostate cancer patient with favourable CYP1B1 isoforms: suggestion for changing paradigms?Giovanni Brandi, Francesco de Rosa, Romano Danesi, et al.
Pageof 17

Showing results (31-40 of 169) with videos related to

Sort By:
Pageof 17
Oncotarget|July 6, 2015
Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapiesGiovanni Brandi, Andrea Farioli, Annalisa Astolfi, et al.
Journal of Translational Medicine|June 5, 2017
Erratum to: The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)Margherita Nannini, Milena Urbini, Annalisa Astolf, et al.
Journal of Translational Medicine|May 25, 2017
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)Margherita Nannini, Milena Urbini, Annalisa Astolfi, et al.
Histology and Histopathology|October 17, 2013
Insulin-like Growth Factor (IGF) system and gastrointestinal stromal tumours (GIST): present and futureMargherita Nannini, Guido Biasco, Annalisa Astolfi, et al.
Hepatology (Baltimore, Md.)|December 24, 2016
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible preventionGiovanni Brandi, Stefania De Lorenzo, Andrea Palloni, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 18, 2012
Hedgehog signaling: from the cuirass to the heart of pancreatic cancerMariacristina Di Marco, Marina Macchini, Silvia Vecchiarelli, et al.
Journal of Translational Medicine|August 16, 2014
Liquid biopsy in gastrointestinal stromal tumors: a novel approachMargherita Nannini, Annalisa Astolfi, Milena Urbini, et al.
Cutaneous and Ocular Toxicology|March 29, 2013
Cutaneous leukocytoclastic vasculitis due to erlotinib: just an adverse event or also a putative marker of drug efficacy?Giovanni Brandi, Michela Venturi, Emi Dika, et al.
Cancer Treatment Reviews|November 17, 2009
Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapyMaria Abbondanza Pantaleo, Margherita Nannini, Monica Di Battista, et al.
European Urology|July 29, 2008
Durable complete response to frontline docetaxel in an advanced prostate cancer patient with favourable CYP1B1 isoforms: suggestion for changing paradigms?Giovanni Brandi, Francesco de Rosa, Romano Danesi, et al.
Pageof 17